24^th World Radiation Oncology Summit

About Conference

welcome to the 24th World Radiation Oncology Summit June 27-28, 2023 Chicago, USA, as a webinar with a theme “Insight into the advances in Radiology & Oncology”. Radiation Oncology-2023 Conference will focus on Educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational Workshop sessions, and influential plenary presentations. RADIATION ONCOLOGY-2023 is a perfect platform to find out how cancer and Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during   presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Radiation, oncology and medical sectors.

Why to attend:

Radiation Oncology 2023 is an international platform for presenting research about diagnosis, prevention and management and exchanging ideas about it and thus, contributes to the dissemination of knowledge in Oncology and Radiology for the benefit of both the Academia and business.

The organizing committee of this Oncology and Radiology Conference is gearing up for an exciting and informative conference program including Plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Radiation Oncology 2023, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the RADIATION ONCOLOGY 2023 Conference and Organizing Committee look forward to meeting you in conference. .

The International Research Conference is a Allied association devoted to bringing together a significant number of different scholarly events for donation within the conference program. Events will run over a span of time during the conference depending on the number and length of the donations. With its high quality, it provides an exceptional value for scholars, academics and assiduity experimenters.

The end of this educational meeting is to partake up-to- date transnational guidelines for the care of TD and to apply them in Clinical operation in diurnal practice. Interaction and exchange of experience and ideas will be enforced through clinical case studies and practice sessions. This is a best Globalized opportunity to reach the largest assemblage of participants from the Scientific Community and research. Conduct presentations, meet with current, potential scientists, distribute information and make a splash with new cancer research developments, and receive name recognition at this event. Renowned speakers and therefore the most up-to-date techniques, developments, the most recent updates in oncology are hallmarks of this conference.

Sessions & Tracks

Track 1: Radiation Oncology

Radiation remedy or radiotherapy, frequently shortened is a remedy using ionizing radiation, generally handed as part of cancer treatment to control or kill nasty cells and typically delivered by a direct accelerator. Radiation remedy may be restorative in a number of types of cancer if they're localized to one area of the body. It may also be used as part of adjuvant remedy, to help excrescence rush after surgery to remove a primary nasty excrescence. Radiation remedy is synergistic with chemotherapy and has been used before during and after chemotherapy in susceptible cancers.

Track 2: Neuro Radiology

Neurology deals with the opinion and treatment of all orders of conditions and complaint involving the brain, the spinal cord and the supplemental jitters. Neuroradiology is a subspecialty of radiology fastening on the opinion and characterization of abnormalities of the central and supplemental nervous system, chine, and head and neck using neuroimaging ways. Medical issues exercising neuroradiology include arteriovenous deformations, excrescences, aneurysms, and strokes.

Track 3: Surgical Oncology

Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical operation of excrescences, especially cancerous excrescences. As one of several modalities in the operation of cancer, the specialty of surgical oncology has evolved in way analogous to medical oncology( pharmacotherapy for cancer), which grew out of hematology, and radiation oncology, which grew out of radiology. The Ewing Society known moment as the Society of Surgical Oncology was started by surgeons interested in promoting the field of oncology.

Track 4: Radiopharmaceuticals

Radiopharmaceuticals or medicinal radio compounds, are a group of pharmaceutical medicines containing radioactive isotopes. Radiopharmaceuticals can be used as individual and remedial agents. Radiopharmaceuticals emit radiation themselves, which is different from discrepancy media which absorb or alter external electromagnetism or ultrasound. Radio pharmacology is the branch of pharmacology that specializes in these agents.

Track 5: Radiosurgery

Radiosurgery is surgery using radiation that is, the destruction of precisely named areas of towel using ionizing radiation rather than excision with a blade. Like other forms of radiation remedy it's generally used to treat cancer. In stereotactic radiosurgery the word" stereotactic" refers to a three- dimensional match system that enables accurate correlation of a virtual target seen in the case's individual images with the factual target position in the case.

Track 6: Oncology Nursing

An oncology nanny is a technical nanny who cares for cancer cases. These nursers bear advanced instruments and clinical gests in oncology further than the typical baccalaureate nursing program provides. Oncology nursing care can be defined as meeting the colorful requirements of oncology cases during the time of their complaint including applicable wireworks and other preventative practices, symptom operation, care to retain as important normal functioning as possible, and probative measures upon end of life.

Track 7: Cancer Biomarkers

A cancer biomarker refers to a substance or process that's reflective of the presence of cancer in the body. A biomarker may be a patch buried by a excrescence or a specific response of the body to the presence of cancer. inheritable, epigenetic, proteomic, glycomic and imaging biomarkers can be used for cancer opinion, prognostic, and epidemiology. Immaculately, similar biomarkers can be assayed innon-invasively collected memoir fluids like blood or serum.

Track 8: Cancer Stem Cells

Cancer stem cells( CSCs) are cancer cells that retain characteristics associated with normal stem cells, specifically the capability to give rise to all cell types set up in a particular cancer sample. CSCs are thus tumorigenic ( excrescence- forming), maybe in discrepancy to other non-tumorigenic cancer cells. CSCs may induce excrescences through the stem cell processes of tone- renewal and isolation into multiple cell types. similar cells are hypothecated to persist in excrescences as a distinct population and beget relapse and metastasis by giving rise to new excrescences.

Track 9: Breast Cancer

Breast cancer is cancer that develops from breast tissue .Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. Risk factors for developing breast cancer include obesity, a lack of physical exercise, alcoholism, hormone replacement therapy during menopause, ionizing radiation.

Track 10: Cardio Oncology

Cardio oncology, cardio- oncology or cardiovascular oncology is an interdisciplinary field of drug by which are studied the molecular and clinical differences in cardiovascular system during the different styles of treatment of cancer, especially chemotherapy and targeted therapy. Cardio- oncology. Has developed as a new translational and clinical field grounded on the expanding force of medium- grounded cancer curatives.

Track 11: Immuno-Oncology

Cancer immunotherapy comes in a variety of forms, including targeted antibodies, cancer vaccines, consanguineous cell transfer, excrescence- infecting contagions, checkpoint impediments, cytokines, and adjuvants. Immunotherapies are a form of biotherapy( also called birth remedy or natural response modifier( BRM) remedy) because they use accoutrements from living organisms to fight complaint.

Track 12: medical Oncology

Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an oncologist. This is only feasible when there is some degree of certainty that the tumor can in fact be removed. When it is certain that parts will remain, curative surgery is often impossible, e.g. when there are metastases elsewhere, or when the tumor has invaded a structure that cannot be operated upon without risking the patient's life.

Track 13: Pediatric Oncology

Pediatric cancer is cancer in a child. In the United States, an arbitrarily espoused standard of the periods used are 0 – 14 times inclusive, that is, up to 14 times11.9 months of age. still, the description of nonage cancer occasionally includes adolescents between 15 and 19 times old. Pediatric oncology is the branch of drug concerned with the opinion and treatment of cancer in children. Children with cancer are at threat for developing colorful cognitive or literacy problems.

Track 14: Gynecologic Oncology

Gynecologic oncology is a technical field of drug that focuses on cancers of the womanish reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they've expansive training in the opinion and treatment of these cancers. There's low quality substantiation which demonstrates women with gynecological cancer entering treatment from technical centers profit from longer survival than those managed in standard care.

Track 15: Radiological applications

Radiology plays a huge role in disease management by giving physicians more options, tools, and techniques for detection and treatment. Diagnostic imaging allows for detailed information about structural or disease-related changes. With the ability to diagnose during the early stages, patients may be saved It is used to diagnose or treat patients by recording images of the internal structure of the body to assess the presence or absence of disease, foreign objects, and structural damage or anomaly. During a radiographic procedure, an x-ray beam is passed through the body. The most widely used radioactive pharmaceutical for diagnostic studies in nuclear medicine. Different chemical forms are used for brain, bone, liver, spleen and kidney imaging and also for blood flow studies.

Benefits of participation

Advantages of Participating at our Conference

• The advantages of the Speaker  and abstract pages are created in Google on your profile under your name would get worldwide visibility.
• Our comprehensive Online Advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our webinar.
• Meet with hundreds of like-minded experts who are pioneers in Oncology and share ideas.
• All participants in the  Conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
• A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of Oncology at our Keynote sessions.
• Radiation Oncology  intensive webinar schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
• Best Poster Award nominations.
• Award for Outstanding Young Researcher.
• Group Registration Advantages.

Benefits of Participation for Speaker

• Worldwide appreciation of the profile of Researchers.
• Obtain credits for professional growth.
• Explore the latest of cutting edge analysis.
• Make long-term bonds at Social And Networking activities.
• An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
• Learn a transition beyond your area of interest to learn more about new subjects and studies away from your  core subject of Oncology.
• We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

• Professional Development-Improve understanding and  Knowledge.
• Attendance at webinars supports rejuvenates and energises delegates.
• Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of Businesses or industries.
• Opportunities for Radiation Oncology researchers and experts in the same field to meet and exchange new ideas through an Online Webinar.

Benefit of Participation for Sponsor

• Exposure to the international environment would increase the possibility of  New Companies.
• Opportunity to demonstrate your company's Latest Technologies, new products, or service your business to a wide range of international participants.
• Increase business by our webinar participants through lead generation.
• It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of Colleagues and associates to draw energy from individuals who share a common drive and objective.
• Webinars in neurology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
• Benchmarking main Organization plans and moving it forward.
• Get feedback from trustworthy people at our webinar to your company questions and challenges.
• On our webinar banner, website and other proceedings, branding and Marketing content, the Advertising Logo of your company.

Benefit of Association for Collaborators

• Nobody has these massive visitors to Oncology  in the world; this is the best forum to highlight society.
• Creating long-lasting peer relationships.
• In our Conference banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
• The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
• Your representatives can network to update their knowledge and understanding of your organisation and services with key webinar Delegates.
• Oncology advertising materials such as posters, Brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.

Market Analysis

The global radiation oncology market size was valued at USD 6.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2028. The increasing prevalence of cancer, rising adoption of radiotherapy in cancer treatment, and technological advancements in radiotherapy equipment are some of the major factors driving the market. Technological advancements to improve treatment safety and efficacy are expected to drive the market for radiation oncology. 4D radiotherapy is a combination of 4D imaging and radiotherapy, which allows real-time tracking of a tumor and provides precise information regarding the tumor size, shape, area, and volume. This combination enables physicians to compensate for organ, tumor, or patient movement and deliver a conformal dose.

The key players are also entering strategic collaborations for the advancement of radiotherapy. For instance, in December 2019, Elekta AB collaborated with ViewRay, Inc. for the advancement of MR-guided therapy in oncology. This collaboration aimed to improve MR-Linac technology to benefit clinicians and patients with wider treatment options.

However, the lack of skilled radiotherapy professionals is one of the major factors restraining the growth of the market for radiation oncology. For instance, in developed countries, there are around 2-3 radiation oncologists per 1,000 cancer patients, whereas, Bangladesh report only 0.76 radiation oncologists per 1,000 cancer patients. Similar is the situation in India. Besides, there is a lack of training and education in radiation oncology among physicians in many countries.